{"id":"W2597431707","doi":"10.1200/jco.2012.30.15_suppl.3027","title":"Rational molecularly targeted combinations: A parallel-arm phase I trial of the humanized anti-IGF-1R antibody dalotuzumab (D) in combination with the allosteric AKT inhibitor MK-2206 or the gamma secretase inhibitor MK-0752, in patients with advanced solid tumors.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Rash; Neutropenia; Febrile neutropenia; Adverse effect; Internal medicine; Leukopenia; Pharmacology; Oncology; Toxicity; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001454981,0.002369154,0.001825787,0.0007632807,0.0003544737,0.001132649,0.0012536,0.001196407,0.00332702],"category_scores_gemma":[0.0008917226,0.0008483031,0.001178347,0.0005607685,0.00111057,0.001028195,0.000634408,0.003043501,0.0008966471],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009669675,"about_ca_system_score_gemma":0.001571083,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000893358,"about_ca_topic_score_gemma":0.001610803,"domain_scores_codex":[0.9996064,0.0001605598,0.00002158407,0.00007842408,0.00004357056,0.0000894484],"domain_scores_gemma":[0.9995281,0.00006969443,0.0001047914,0.00005028464,0.00002634615,0.0002208988],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7642344,0.1042222,0.002726563,0.0007181134,0.0006949847,0.0002202184,0.0003186199,0.006456914,0.03438417,0.0005949039,0.002993767,0.08243522],"study_design_scores_gemma":[0.6246396,0.3669915,0.002205441,0.00001697234,0.0001929813,0.0001250349,0.00003181123,0.00129509,0.002915184,0.0002490456,0.001310461,0.00002676802],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926831,0.0009937641,0.0006443702,0.0003212798,0.0001109068,0.003009743,0.0007312701,0.00008602679,0.001419557],"genre_scores_gemma":[0.9879442,0.001595896,0.002381515,0.0004904234,0.0001533193,0.003830604,0.001206942,0.00002720873,0.002369942],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00332702,"threshold_uncertainty_score":0.01112998,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06951995384007696,"score_gpt":0.4592329107391417,"score_spread":0.3897129568990648,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}